News Formal

Irish pharma group Amryt reports record revenues for second quarter

  • 📰 IrishTimes
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 98%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Sales of metreleptin surge for company that specialises in treatment of rare diseases

Irish drugmaker Amryt Pharma has reported record financial results for the second quarter of 2022, with its revenue rising 9.2 per cent year-on-year to $68.5 million .

The year-on-year increase in metreleptin revenues was 49.9 per cent if the impact of a sporadic Latin America order from the second quarter of 2021 is excluded from the comparison.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

One in five Irish pubs have called last orders since 2005, industry group saysReport by Drinks Industry Ireland shows rural pubs have fared worse than their Dublin counterparts IrishTimes In a way this is a good thing - the Irish relationship with alcohol is toxic and unhealthy. *the impact of lockdowns Your supposed to be a reporter. Learn how to spell.
Source: IrishTimesBiz - 🏆 6. / 77 Read more »